Phase Two TB Trials Launched
The AERAS, a non-profit product development organization dedicated to the development of effective tuberculosis (TB) vaccines and the Oxford Emergent Tuberculosis Consortium (OETC) start the second tuberculosis vaccine trials in Senegal and South Africa. The trial is expected to generate important safety, immunogenicity and efficacy data about the vaccine. Source: The Standard, My Health, Pg. 9 Date: Tuesday, 23 Aug 2011 |
- Mtandao Wa InternewsA platform for Kenyan journalists to share stories
- Work with us Opportunities to join the great team!
- Internews E-Learning. Online platform for trainer trainee interaction
- OpportunitiesCurrent and upcoming opportunities for journalists
Mtandao wa Internews-Ushahidi
|
|
|
Play all Audio Reports |